BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Western Australian Health Translation Network - ECPv6.3.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Western Australian Health Translation Network
X-ORIGINAL-URL:https://wahtn.org
X-WR-CALDESC:Events for Western Australian Health Translation Network
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Shanghai
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:CST
DTSTART:20260101T000000
END:STANDARD
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20260101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Asia/Shanghai:20261007T163000
DTEND;TZID=Asia/Shanghai:20261007T173000
DTSTAMP:20261120T162610
CREATED:20260731T034751Z
LAST-MODIFIED:20261008T025931Z
UID:10222-1791390600-1791394200@wahtn.org
SUMMARY:WAHTN CTEP-WA Clinical Trials Forum - October
DESCRIPTION:The WA Clinical Trials Forum is a new initiative of WAHTN and the Clinical Trials Enabling Platform-WA (CTEP-WA) to help support a thriving clinical trials ecosystem in WA by bringing together clinicians and researchers to strengthen the design of clinical trials. \nWednesday 7 October 2026 4:30 PM – 5:30 PM \nRepurposing Probucol for Childhood Dementia: A Phase II Feasibility Study \nChildhood dementia encompasses a group of rare\, progressive neurodegenerative disorders that collectively affect more than 100 genetic conditions\, with no approved disease-modifying therapies for most children. We propose a 52-week\, investigator-initiated\, open-label Phase II feasibility study evaluating oral probucol in children with genetically confirmed Batten disease\, Niemann-Pick disease type C\, Sanfilippo syndrome (MPS III) or Leigh syndrome. The primary objectives are to establish the feasibility of recruitment and retention\, treatment adherence and the safety and tolerability of long-term probucol administration in this population\, while collecting preliminary clinical\, functional and biomarker data to inform future controlled studies. \nDoors will open with light refreshments provided at 4:15pm\, with the presentation and panel starting at 4:30\, ending with a networking session to 6pm. \nVenue: McCusker Auditorium\, at the Harry Perkins Institute of Medical Research\, 6 Verdun St Nedlands WA (QEII Campus) \nThe forum will open at 4:15\, with the presentation and panel starting at 4:30. The day will end with a networking session to 6pm. Light refreshments provided. \nOnline: An online livestream option is available for those who cannot attend in person. Select the ‘Online’ ticket type using the registration link above. \nYou can find out more about the event and register here: https://www.trybooking.com/DNAYR
URL:https://wahtn.org/event/wahtn-ctep-wa-clinical-trials-forum/
LOCATION:McCusker Auditorium\, Harry Perkins Institute of Medical Research\, North Building\, 6 Verdun Street\, Nedlands\, Western Australia\, 6009\, Australia
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20261118T130000
DTEND;TZID=UTC:20261118T140000
DTSTAMP:20261120T162610
CREATED:20261021T055400Z
LAST-MODIFIED:20261021T062538Z
UID:10438-1795006800-1795010400@wahtn.org
SUMMARY:AHRA Implementation Science webinar
DESCRIPTION:From research to reality: The power of implementation science \nHow do we turn evidence into practice? \nJoin the Australian Health Research Alliance (AHRA) for a national webinar exploring the power of implementation science to bridge the gap between research and real-world healthcare. \nHear from experts from the National Health and Medical Research Council (NHMRC) and across AHRA’s Research Translation Centre network\, including WAHTN Implementation Science Platform co-lead Dr Mary Kennedy and consumer representative Rochelle Oaklands. \nWednesday 18 November | 1pm–2pm AEDT \n🔗 Register: https://monash.zoom.us/webinar/register/WN_UvD7OTC1RQqsfgi63I04GQ \nWAHTN is proud to be part of AHRA’s national network supporting research translation and implementation.
URL:https://wahtn.org/event/ahra-implementation-science-webinar/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Shanghai:20261124T163000
DTEND;TZID=Asia/Shanghai:20261124T173000
DTSTAMP:20261120T162610
CREATED:20261112T063705Z
LAST-MODIFIED:20261112T064335Z
UID:10484-1795537800-1795541400@wahtn.org
SUMMARY:WA Clinical Trials Forum - 24 November 2026
DESCRIPTION:The WA Clinical Trials Forum series is a collaborative initiative of WAHTN and CTEP-WA that serves as a form of internal peer review for the WA clinical trials community\, helping to strengthen trial design and support a thriving clinical trials ecosystem in WA. \nWhy attend? \n✓ Hear about proposed WA clinical trials and contribute to the discussion\n✓ Learn from an expert panel including consumers and internationally recognised clinical trialists\n✓ Broaden your exposure to trial design and methodology\n✓ Connect with like-minded clinicians\, consumers and researchers\n✓ Join a growing community of practice of WA clinicians and researchers who propose\, design and conduct high-quality clinical trials. \nThis forum will feature a presentation by Dr Abdul Ihdayhid on the trial ‘Coronary Tomography for FiRst-Line Investigation of Stenosis before TAVI’. \nDate: Tuesday 24 November 2026\nTime: 4:30 – 5:30pm AWST\nFormat: Please note that this forum is online only \nFind out more about the event and register here.
URL:https://wahtn.org/event/wa-clinical-trials-forum-24-november-2026/
ATTACH;FMTTYPE=image/png:https://wahtn.org/wp-content/uploads/2026/07/CTEP-WA-Clin-Trials-Forum-Socials-2-1-e1785482580342.png
END:VEVENT
END:VCALENDAR